Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 13, 2014
Cannabinoid receptor-2 and HIV-associated neurocognitive disordersVishnudutt Purohit, Rao S Rapaka, Joni RutterJournal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 25, 2012
Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?Vishnudutt Purohit, Rao S Rapaka, Joni Rutter, et al.Journal of Neurovirology|March 5, 2013
National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementiaVishnudutt Purohit, Rao Rapaka, Jerry Frankenheim, et al.Drug and Alcohol Dependence|May 14, 2010
Measuring addiction propensity and severity: the need for a new instrumentKevin P Conway, Janet Levy, Michael Vanyukov, et al.Human Molecular Genetics|December 1, 2006
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPsScott F Saccone, Anthony L Hinrichs, Nancy L Saccone, et al.Human Molecular Genetics|December 13, 2006
Novel genes identified in a high-density genome wide association study for nicotine dependenceLaura Jean Bierut, Pamela A F Madden, Naomi Breslau, et al.Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.Genetic Epidemiology|February 11, 2011
Gene-environment interplay in common complex diseases: forging an integrative model—recommendations from an NIH workshopEbony B Bookman, Kimberly McAllister, Elizabeth Gillanders, et al.Pageof 1